<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>171-DEXTRAN-40.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="DEXTRAN 40" rxcui="42635">
<ATC code="B05AA05" />
<ATC code="B03AC06" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="LOW MOLECULAR WEIGHT HEPARINS AND RELATED DRUGS (CURATIVE DOSES AND/OR OLDER PATIENT)" code="B01AB-001" /></DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage (inhibition of the platelet function by the dextran 40)</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>171-DEXTRAN-40.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="DEXTRAN 40" rxcui="42635">
<ATC code="B05AA05" />
<ATC code="B03AC06" />
</DRUG>
</DRUG1>
<DRUG2>
<CLASS name="UNFRACTIONATED HEPARIN (CURATIVE DOSES AND/OR OLDER PATIENT)" code="B01AB-003" /></DRUG2>
<DESCRIPTION>Increase of the risk of hemorrhage (inhibition of the platelet function by the dextran 40)</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
</INTERACTIONS>
